Trials / Completed
CompletedNCT01387607
A Study For Pregabalin In Patients With Fibromyalgia
A 14-week, Randomized, Double-blind Placebo-controlled Study For Pregabalin In Subjects With Fibromyalgia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 343 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and tolerability of pregabalin compared with placebo for management of fibromyalgia in adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pregabalin | Pregabalin capsule, 300-450mg/day, twice daily |
| DRUG | placebo | Placebo, twice daily |
Timeline
- Start date
- 2012-02-06
- Primary completion
- 2016-10-31
- Completion
- 2016-10-31
- First posted
- 2011-07-04
- Last updated
- 2021-01-28
- Results posted
- 2018-07-30
Locations
22 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01387607. Inclusion in this directory is not an endorsement.